Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8.
about
Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43Molecular mechanism of hTid-1, the human homolog of Drosophila tumor suppressor l(2)Tid, in the regulation of NF-kappaB activity and suppression of tumor growthThe NF-κB Pathway and Cancer Stem CellsFucoidan as a Potential Therapeutic for Major Blinding Diseases--A HypothesisThe immunological effect of hyaluronan in tumor angiogenesisTranscriptional regulation of chemokine expression in ovarian cancerTargeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategyContemporary use of bevacizumab in ovarian cancerTo NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate RegulatorInduction of Bcl-2 expression by hepatitis B virus pre-S2 mutant large surface protein resistance to 5-fluorouracil treatment in Huh-7 cellsAssociation of an NFKB1 intron SNP (rs4648068) with gastric cancer patients in the Han Chinese populationIdentification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.Ovarian tumor attachment, invasion, and vascularization reflect unique microenvironments in the peritoneum: insights from xenograft and mathematical models.Effects of IkappaBalpha and its mutants on NF-kappaB and p53 signaling pathways.In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic CarcinomaCurcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumorsHsp90 inhibitor SY-016 induces G2/M arrest and apoptosis in paclitaxel-resistant human ovarian cancer cellsWNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3The role of dysregulated glucose metabolism in epithelial ovarian cancer.The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxiaThe 3020insC Allele of NOD2 Predisposes to Cancers of Multiple OrgansRole of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies.Palliative treatment of malignant ascites: profile of catumaxomab.Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult miceVEGFR2 translocates to the nucleus to regulate its own transcription.Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunitiesTranscriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells.Recent insights into the role of NF-kappaB in ovarian carcinogenesis.Nuclear Factor-κB modulates cellular glutathione and prevents oxidative stress in cancer cells.Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology GroupNF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis.Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo.Combination of Medicinal Herbs KIOM-79 Reduces Advanced Glycation End Product Accumulation and the Expression of Inflammatory Factors in the Aorta of Zucker Diabetic Fatty Rats.Local therapies for inflammatory eye disease in translation: past, present and futureGenomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer.NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progression.Adhesion and migration of ovarian cancer cells on crosslinked laminin fibers nanofabricated by multiphoton excited photochemistryAnti-cancer role of SPARC, an inhibitor of adipogenesisThe biphasic role of NF-kappaB in progression and chemoresistance of ovarian cancer.Microenvironment and pathogenesis of epithelial ovarian cancer
P2860
Q21254678-D89335BB-104E-4657-81CF-7FC6E818D7E6Q24322578-0B9B09B8-E192-4D1B-A811-E282BA67507AQ26750605-4A2FB0C0-6357-4026-8C34-A447B96BAFDDQ26768638-ED232D7D-668F-405A-A2A0-ABAEE2110061Q26771483-7E643CC8-962C-4E11-8FF9-26541F2382F6Q26825361-8FD08162-D4E3-4DAB-A51D-5BCC98195D3AQ26863340-2C7310B0-673E-432D-A386-A83031E80451Q27023510-C8D28A6A-491C-430C-A55E-D3A6CB6D4E8CQ28386593-F32EC4BB-2341-4E91-A7F4-C7FC600B04DDQ28478544-EA3CAFE1-C331-4097-AE5F-8ADCC5316F61Q28728691-331ECEB4-0C50-4379-935A-023D42B794CAQ30312189-9F8D44C6-6E71-495A-9EDB-4A959474A1E8Q30539859-ECD09E79-C234-462C-87A3-7A105415B274Q33262194-FE48B0DC-B780-452C-8A82-AE977424E2EEQ33286433-1C4623CF-7628-4C83-9453-E0C3F05DD73CQ33590593-59CB57D3-38A9-4ED9-91B9-E6389EE036C4Q33598733-C5AACA8A-73E7-45AD-BD55-68953A9A2D6DQ33634911-E13D75A8-00CB-46D1-97FE-182021552495Q33674221-6DF17646-6467-4DE2-927A-0C8AC1BD10EBQ33690020-B55F4432-6688-4B0E-B94B-A3BA1D0E2160Q33722537-B32592A6-D2B6-4A56-B71A-5E80A00594E6Q33771212-61FDFC18-84DA-41BC-9212-AE442B4399CBQ33892606-FC4AAE80-E916-479E-BF95-C93DFCABF263Q34020968-FD81793B-6D99-4488-9642-8CA68302F3FDQ34043465-0600B266-BD0F-4AA4-A98A-E6F28B73ACD6Q34139691-3CD14F20-5492-438D-9A55-BB96ACC8D42CQ34146733-FB20169D-DC1A-4046-8A0E-172530E93254Q34152899-D4C125B6-7D2D-4115-A0A6-0749DCF4CF42Q34209307-155A4337-64F6-48A9-8F1C-F92930E0BB7DQ34225158-2A3B1638-C283-485A-A177-64F6B1027DC7Q34324711-6EB2B3D9-17C3-4FBD-9122-2FF4DB8199E8Q34441618-62513375-C3B6-444D-BE9C-7D12DD761E88Q34591116-7489189D-0BB5-4B04-8409-7DC0FA7DCDA1Q34892662-47A8C4BE-66A7-4820-845E-C2FF932BDFA2Q35058278-64AAF1DB-33E9-486F-A6F2-89781545CC43Q35095325-EBBC2BEE-FBD4-45BF-BCE0-984A50F8DDC5Q35112266-96A267D9-0217-49AD-AE22-A1EF0F210192Q35116107-02EEB108-EBC1-43E5-8F58-CD4F883EC7B3Q35154638-BDFC9479-12AC-4D4D-BB31-CE046915FD5DQ35419057-595D9A00-3041-4FB2-BAB7-287B320E3A44
P2860
Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Blockade of nuclear factor-kap ...... owth factor and interleukin 8.
@en
Blockade of nuclear factor-kap ...... owth factor and interleukin 8.
@nl
type
label
Blockade of nuclear factor-kap ...... owth factor and interleukin 8.
@en
Blockade of nuclear factor-kap ...... owth factor and interleukin 8.
@nl
prefLabel
Blockade of nuclear factor-kap ...... owth factor and interleukin 8.
@en
Blockade of nuclear factor-kap ...... owth factor and interleukin 8.
@nl
P2093
P1433
P1476
Blockade of nuclear factor-kap ...... owth factor and interleukin 8.
@en
P2093
A Deguzman
C D Bucana
I J Fidler
J B Robinson
P304
P407
P577
2000-10-01T00:00:00Z